Medtronic Total Liabilities & Equity increased by 0.2% to $91.49B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.7%, from $89.97B to $91.49B. Over 4 years (FY 2021 to FY 2025), Total Liabilities & Equity shows relatively stable performance with a -0.4% CAGR.
An increase typically reflects overall balance sheet growth or expansion of the company's asset base, while a decrease may indicate divestitures or debt repayment.
This represents the sum of all claims against a company's assets, combining obligations to external creditors and the re...
This is a standard accounting identity used across all industries to verify that assets equal the sum of liabilities and equity.
total_liabilities_and_equity| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $91.80B | $91.76B | $91.80B | $90.98B | $89.91B | $93.24B | $94.13B | $90.95B | $90.78B | $90.09B | $90.84B | $89.98B | $89.75B | $90.04B | $89.97B | $91.68B | $90.97B | $91.35B | $91.49B |
| QoQ Change | — | -0.1% | +0.1% | -0.9% | -1.2% | +3.7% | +1.0% | -3.4% | -0.2% | -0.8% | +0.8% | -0.9% | -0.3% | +0.3% | -0.1% | +1.9% | -0.8% | +0.4% | +0.2% |
| YoY Change | — | — | — | — | -2.1% | +1.6% | +2.5% | -0.0% | +1.0% | -3.4% | -3.5% | -1.1% | -1.1% | -0.0% | -1.0% | +1.9% | +1.4% | +1.4% | +1.7% |